PROBIOFLORA LTD

Executive Summary

PROBIOFLORA LTD is a newly formed dormant company with minimal financial resources and no active trading. While compliance with filing requirements is maintained, the absence of operational data and cash flow presents a high risk from a solvency and liquidity standpoint. Investors should closely examine the company’s plans to commence trading and secure funding before considering investment.

PROBIOFLORA LTD - Analysis Report

Company Number: 15146252

Analysis Date: 2025-07-29 16:39 UTC

1. Risk Rating: HIGH
   Justification: PROBIOFLORA LTD is a recently incorporated company (2023) classified as dormant with nominal net assets (£1.10) and virtually no cash (£1). There are no trading activities or financial data indicating revenue generation or operational cash flow. This implies an inability to currently meet financial obligations or sustain operations independently.

2. Key Concerns:

• Dormant Status: The company has filed dormant accounts, indicating no active trading or income generation to support operational costs or liabilities.
• Minimal Financial Resources: The balance sheet shows only £1 cash and net assets of £1.10, which is insufficient to cover any liabilities or investments required for growth.
• Single Director and Shareholder Control: Mr. Reza Dayer holds 100% ownership and directorship, which concentrates control and may increase governance risks if not supported by external oversight.

3. Positive Indicators:

• Compliance with Filings: The company is up to date with its statutory accounts and confirmation statement filings, indicating adherence to regulatory requirements.
• Clear Ownership and Control Structure: Transparency in significant control with a single PSC simplifies accountability.
• Industry Classification: The company is registered under SIC 72110 (biotechnology research and experimental development), which is a sector with high growth potential, assuming future operational commencement.

4. Due Diligence Notes:

• Investigate Business Plan and Funding: Assess whether capital injection or funding arrangements are planned to transition from dormant to active trading status.
• Verify Future Operational Intentions: Confirm timelines for commencing trading activities and expected revenue streams.
• Review Director’s Background: Evaluate the experience and capacity of Mr. Dayer to manage and grow the company effectively, including any relevant prior business or scientific expertise.
• Monitor for Changes in Financials: Track upcoming accounts for evidence of operational activity, liquidity improvements, or asset acquisitions.